Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 350 articles:
HTML format



Single Articles


    May 2020
  1. MUKHERJEE M, Forero DF, Tran S, Boulay ME, et al
    Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.
    Eur Respir J. 2020 May 22. pii: 13993003.00117-2020.
    PubMed     Abstract available


  2. BAGGOTT C, Hardy J, Sparks J, Holliday M, et al
    Self-titration of inhaled corticosteroid and beta2-agonist in response to symptoms in mild asthma - a pre-specified analysis from the PRACTICAL study, a randomised controlled trial.
    Eur Respir J. 2020 May 22. pii: 13993003.00170-2020.
    PubMed     Abstract available


  3. ROGLIANI P, Ritondo BL, Ora J, Cazzola M, et al
    SMART and as-needed therapies in mild to severe asthma: a network meta-analysis.
    Eur Respir J. 2020 May 19. pii: 13993003.00625-2020.
    PubMed     Abstract available


  4. TAYTARD J, Aupiais C, Jovien S, Assouline Kabla J, et al
    Effect of Long-Acting Beta-Agonist on bronchodilator response in asthmatic children.
    Eur Respir J. 2020 May 19. pii: 13993003.02010-2019.
    PubMed    


  5. SINGH D, Virchow JC, Canonica GW, Vele A, et al
    Extrafine triple therapy in patients with asthma and persistent airflow limitation.
    Eur Respir J. 2020 May 19. pii: 13993003.00476-2020.
    PubMed    


  6. ALIBERTI S, Sotgiu G, Blasi F, Saderi L, et al
    Blood eosinophils predict inhaled fluticasone response in bronchiectasis.
    Eur Respir J. 2020 May 12. pii: 13993003.00453-2020.
    PubMed    


  7. EXARCHOS KP, Beltsiou M, Votti CA, Kostikas K, et al
    Artificial Intelligence techniques in Asthma:A systematic review and critical appraisal of the existing literature.
    Eur Respir J. 2020 May 7. pii: 13993003.00521-2020.
    PubMed     Abstract available


  8. HOANG TT, Sikdar S, Xu CJ, Lee MK, et al
    Epigenome-Wide Association Study of DNA Methylation and Adult Asthma in the Agricultural Lung Health Study.
    Eur Respir J. 2020 May 7. pii: 13993003.00217-2020.
    PubMed     Abstract available


  9. TAYLOR SL, Ivey KL, Gibson PG, Simpson JL, et al
    Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma.
    Eur Respir J. 2020 May 4. pii: 13993003.00194-2020.
    PubMed    


  10. COSTELLO RW, Cushen B
    Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma.
    Eur Respir J. 2020;55.
    PubMed    


  11. LEUNG JM, Yang CX, Tam A, Shaipanich T, et al
    ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.
    Eur Respir J. 2020;55.
    PubMed    


  12. DINH-XUAN AT, Brusselle G
    F ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma.
    Eur Respir J. 2020;55.
    PubMed    


    April 2020
  13. HANSEN ESH, Pitzner-Fabricius A, Toennesen LL, Rasmusen HK, et al
    Effect of aerobic exercise training on asthma in adults - A systematic review and meta-analysis.
    Eur Respir J. 2020 Apr 29. pii: 13993003.00146-2020.
    PubMed     Abstract available


  14. TOPPILA-SALMI S, Luukkainen AT, Xu B, Lampi J, et al
    Maternal smoking during pregnancy affects adult onset of asthma in offspring: a follow up from birth to age 46 years.
    Eur Respir J. 2020 Apr 27. pii: 13993003.01857-2019.
    PubMed     Abstract available


  15. PRETEROTI M, Whitmore GA, Vandemheen KL, Mark FitzGerald J, et al
    Population-Based Case-Finding to Identify Subjects with Undiagnosed Asthma or COPD.
    Eur Respir J. 2020 Apr 16. pii: 13993003.00024-2020.
    PubMed     Abstract available


  16. IJPMA G, Kachmar L, Panariti A, Matusovsky OS, et al
    Intrapulmonary airway smooth muscle is hyperreactive with a distinct proteome in asthma.
    Eur Respir J. 2020 Apr 16. pii: 13993003.02178-2019.
    PubMed     Abstract available


  17. GEHRING U, Wijga AH, Koppelman GH, Vonk JM, et al
    Air pollution and the development of asthma from birth until young adulthood.
    Eur Respir J. 2020 Apr 16. pii: 13993003.00147-2020.
    PubMed     Abstract available


  18. BONVINI SJ, Birrell MA, Dubuis E, Adcock JJ, et al
    Novel airway smooth muscle-mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma.
    Eur Respir J. 2020 Apr 16. pii: 13993003.01458-2019.
    PubMed     Abstract available


  19. TURK Y, Theel W, van Huisstede A, van de Geijn GM, et al
    Short-term and long-term effect of a high intensity pulmonary rehabilitation program in obese patients with asthma: a randomised controlled trial.
    Eur Respir J. 2020 Apr 16. pii: 13993003.01820-2019.
    PubMed     Abstract available


  20. NEALE J, Orme MW, Majd S, Chantrell S, et al
    A comparison of daily physical activity profiles between adults with severe asthma and healthy controls.
    Eur Respir J. 2020 Apr 7. pii: 13993003.02219-2019.
    PubMed    


  21. CRICHTON ML, Lonergan M, Barker AF, Sibila O, et al
    Inhaled Aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies.
    Eur Respir J. 2020 Apr 7. pii: 13993003.00608-2020.
    PubMed     Abstract available


  22. TAILLE C, Chanez P, Devouassoux G, Didier A, et al
    Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.
    Eur Respir J. 2020 Apr 2. pii: 13993003.02345-2019.
    PubMed     Abstract available


  23. CHARRIOT J, Gaga M, Suehs C, Bourdin A, et al
    Asthma rescue treatments, time to reboot.
    Eur Respir J. 2020;55.
    PubMed    


  24. CELLI B, Fabbri LM
    Urgent need of a management plan for survivors of COVID-19.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  25. NANZER A, Chowdhury A, Raheem A, Roxas C, et al
    Prevalence and Recovery of Adrenal Insufficiency in Steroid-Dependent Asthma Patients Receiving Biologic Therapy.
    Eur Respir J. 2020 Mar 26. pii: 13993003.02273-2019.
    PubMed    


  26. VROMAN H, Tindemans I, Lukkes M, van Nimwegen M, et al
    Type II conventional DCs of asthmatic patients with frequent exacerbations have an altered phenotype and frequency.
    Eur Respir J. 2020 Mar 26. pii: 13993003.00859-2019.
    PubMed    


  27. ALCARAZ-SERRANO V, Gimeno-Santos E, Scioscia G, Gabarrus A, et al
    Association between physical activity and risk of hospitalisation in bronchiectasis.
    Eur Respir J. 2020 Mar 17. pii: 13993003.02138-2019.
    PubMed     Abstract available


  28. ALI MK, Kim RY, Brown AC, Mayall JR, et al
    Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma.
    Eur Respir J. 2020 Mar 17. pii: 13993003.01340-2019.
    PubMed     Abstract available


  29. HANCOX RJ, Morgan J, Dickson N, Connor J, et al
    Rape, asthma, and dysfunctional breathing.
    Eur Respir J. 2020 Mar 17. pii: 13993003.02455-2019.
    PubMed    


  30. FIELDING SS, Pijnenburg M, de Jongste J, Pike K, et al
    Does treatment guided by fractional exhaled nitric oxide improve outcomes in subgroups of children with asthma?
    Eur Respir J. 2020 Mar 12. pii: 13993003.01879-2019.
    PubMed     Abstract available


  31. TRAN TN, King E, Sarkar R, Nan C, et al
    Oral Corticosteroid Prescription Patterns for Asthma in France, Germany, Italy, and the United Kingdom.
    Eur Respir J. 2020 Mar 12. pii: 13993003.02363-2019.
    PubMed     Abstract available


  32. GEALE K, Darabi H, Lindh M, Wahl HF, et al
    NORDSTAR - Paving the way for a new era in asthma research.
    Eur Respir J. 2020 Mar 12. pii: 13993003.02476-2019.
    PubMed    


  33. SHAHEEN SO, Gissler M, Devereux G, Erkkola M, et al
    Maternal iron supplementation in pregnancy and asthma in the offspring: follow-up of a randomised trial in Finland.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02335-2019.
    PubMed    


  34. WANG K, Verbakel JY, Oke J, Fleming-Nouri A, et al
    Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02150-2019.
    PubMed     Abstract available


  35. SLOB EMA, Brew BK, Vijverberg SJH, Kats CJAR, et al
    Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02021-2019.
    PubMed     Abstract available


  36. HARVEY ES, Langton D, Katelaris C, Stevens S, et al
    Mepolizumab effectiveness and identification of super-responders in severe asthma.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02420-2019.
    PubMed     Abstract available


  37. LIPWORTH B, Kuo CR, Chan R
    Systemic potency of fluticasone in asthma.
    Eur Respir J. 2020;55.
    PubMed    


  38. BUSSE WW
    Treatable traits: a step closer to the "holy grail" of asthma control?
    Eur Respir J. 2020;55.
    PubMed    


    February 2020
  39. DEVULDER J, Chenivesse C, Ledroit V, Fry S, et al
    Aberrant anti-viral response of Natural Killer cell in severe asthma.
    Eur Respir J. 2020 Feb 27. pii: 13993003.02422-2018.
    PubMed     Abstract available


  40. D'ANCONA G, Kavanagh J, Roxas C, Green L, et al
    Adherence to Inhaled Corticosteroids and Clinical Outcomes in Mepolizumab Therapy for Severe Asthma.
    Eur Respir J. 2020 Feb 20. pii: 13993003.02259-2019.
    PubMed     Abstract available


  41. BAGGOTT C, Reddel HK, Hardy J, Sparks J, et al
    Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma - findings from the PRACTICAL study, a randomised clinical trial.
    Eur Respir J. 2020 Feb 6. pii: 13993003.02073-2019.
    PubMed     Abstract available


  42. REDDEL HK
    GINA recommendations in adults with symptomatic mild asthma and a smoking history.
    Eur Respir J. 2020;55.
    PubMed    


  43. THOMSON NC, Chaudhuri R
    GINA recommendations in adults with symptomatic mild asthma and a smoking history.
    Eur Respir J. 2020;55.
    PubMed    


  44. SCHLEICH FN, Zanella D, Focant JF
    Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
    Eur Respir J. 2020;55.
    PubMed    


    January 2020
  45. BACHERT C, Humbert M, Hanania NA, Zhang N, et al
    Staphylococcus aureus and its IgE-inducing Enterotoxins in Asthma: Current Knowledge.
    Eur Respir J. 2020 Jan 24. pii: 13993003.01592-2019.
    PubMed     Abstract available


  46. COTTIN V, Nasser M, Traclet J, Chalabreysse L, et al
    Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult.
    Eur Respir J. 2020 Jan 24. pii: 13993003.01952-2019.
    PubMed    


  47. HULS A, Vanker A, Gray D, Koen N, et al
    Genetic susceptibility to asthma increases the vulnerability to indoor air pollution.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01831-2019.
    PubMed     Abstract available


  48. MENZIES-GOW A, Mansur AH, Brightling CE
    Clinical utility of fractional exhaled nitric oxide (FeNO) in severe asthma management.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01633-2019.
    PubMed     Abstract available


  49. NWARU BI, Ekstrom M, Hasvold P, Wiklund F, et al
    Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01872-2019.
    PubMed     Abstract available


  50. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.
    Eur Respir J. 2020;55.
    PubMed    


    December 2019
  51. KIM S, Forno E, Yan Q, Jiang Y, et al
    SNPs identified by GWAS affect asthma risk through DNA methylation and expression of cis-genes in airway epithelium.
    Eur Respir J. 2019 Dec 12. pii: 13993003.02079-2019.
    PubMed     Abstract available


  52. ARSHAD SH, Hodgekiss C, Holloway JW, Kurukulaaratchy R, et al
    Association of asthma and smoking with lung function impairment in adolescence and early adulthood; the Isle of Wight Birth Cohort Study.
    Eur Respir J. 2019 Dec 12. pii: 13993003.00477-2019.
    PubMed     Abstract available


  53. MCDONALD VM, Clark VL, Cordova-Rivera L, Wark PAB, et al
    Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01509-2019.
    PubMed     Abstract available


  54. SERAJEDDINI H, Eddy RL, Licskai C, McCormack DG, et al
    FEV1 and MRI Ventilation Defect Reversibility in Asthma and COPD.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01947-2019.
    PubMed    


  55. CABRERA CS, Nan C, Lindarck N, Beekman MJHI, et al
    SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting beta2-agonist use in asthma.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01858-2019.
    PubMed     Abstract available


  56. FOY B, Kay D, Siddiqui S, Brightling C, et al
    Increased ventilation heterogeneity in asthma can be attributed to proximal bronchioles.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01345-2019.
    PubMed    


  57. TO T, Zhu J, Stieb D, Gray N, et al
    Early Life Exposure to Air Pollution and Incidence of Childhood Asthma, Allergic Rhinitis and Eczema.
    Eur Respir J. 2019 Dec 5. pii: 13993003.00913-2019.
    PubMed     Abstract available


  58. BOUSQUET J, Anto JM, Bachert C, Bosnic-Anticevich S, et al
    From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.
    Eur Respir J. 2019;54.
    PubMed    


    November 2019
  59. ABDULLAH K, Zhu J, Gershon A, Dell S, et al
    Effect of asthma exacerbation during pregnancy in women with asthma: A population-based cohort study.
    Eur Respir J. 2019 Nov 26. pii: 13993003.01335-2019.
    PubMed     Abstract available


  60. KIM YM, Kim H, Lee S, Kim S, et al
    Airway G-CSF identifies neutrophilic inflammation and contributes to asthma progression.
    Eur Respir J. 2019 Nov 19. pii: 13993003.00827-2019.
    PubMed     Abstract available


  61. WANG L, Chitano P, Pare PD, Seow CY, et al
    Upregulation of smooth muscle Rho-kinase protein expression in human asthma.
    Eur Respir J. 2019 Nov 14. pii: 13993003.01785-2019.
    PubMed    


  62. OSEI ET, Brandsma CA, Timens W, Heijink IH, et al
    Current perspectives on the role of Interleukin-1 signaling in the pathogenesis of Asthma and COPD.
    Eur Respir J. 2019 Nov 14. pii: 13993003.00563-2019.
    PubMed     Abstract available


  63. VERMEULEN CJ, Xu CJ, Vonk JM, Ten Hacken NHT, et al
    Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission.
    Eur Respir J. 2019 Nov 14. pii: 13993003.01280-2019.
    PubMed     Abstract available


  64. GIBSON PG, Foster PS
    Neutrophilic asthma: welcome back!
    Eur Respir J. 2019;54.
    PubMed    


  65. REDDEL HK
    Response: The most fundamental change in asthma management in 30 years?
    Eur Respir J. 2019;54.
    PubMed    


  66. AMIRAV I, Newhouse MT
    The most fundamental change in asthma management in 30 years?
    Eur Respir J. 2019;54.
    PubMed    


  67. GAGA M, Zervas E
    Oral steroids in asthma: a double-edged sword.
    Eur Respir J. 2019;54.
    PubMed    



  68. ERJ November Podcast: Macrolides in severe asthma.
    Eur Respir J. 2019;54.
    PubMed    


    October 2019
  69. COSTA CM, Neder JA, Verrastro CG, Paula-Ribeiro M, et al
    Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema.
    Eur Respir J. 2019 Oct 24. pii: 13993003.01319-2019.
    PubMed     Abstract available


  70. RADEMACHER J, Konwert S, Fuge J, Dettmer S, et al
    Anti-IL5 and anti-IL5Ralpha therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01333-2019.
    PubMed    


  71. KATAYAMA S, Hammar KS, Krjutskov K, Einarsdottir E, et al
    Acute wheeze-specific gene module shows correlation with vitamin D and asthma medication.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01330-2019.
    PubMed     Abstract available


  72. ZHU Z, Zhu X, Liu CL, Shi H, et al
    Shared Genetics of Asthma and Mental Health Disorders: A Large-Scale Genome-Wide Cross-Trait Analysis.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01507-2019.
    PubMed     Abstract available


  73. FITZGERALD JM, Buhl R, Casale TB, Jugovic B, et al
    Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma.
    Eur Respir J. 2019 Oct 16. pii: 13993003.00964-2019.
    PubMed    


  74. TANG HHF, Sly PD, Holt PG, Holt KE, et al
    Systems biology and big data in asthma and allergy - recent discoveries and emerging challenges.
    Eur Respir J. 2019 Oct 16. pii: 13993003.00844-2019.
    PubMed     Abstract available


  75. DIMA AL, van Ganse E, Stadler G, de Bruin M, et al
    Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study.
    Eur Respir J. 2019 Oct 10. pii: 13993003.00901-2019.
    PubMed     Abstract available


  76. VAN BRAGT JJMH, Adcock IM, Bel EHD, Braunstahl GJ, et al
    Characteristics and treatment regimens across ERS SHARP severe asthma registries.
    Eur Respir J. 2019 Oct 10. pii: 13993003.01163-2019.
    PubMed     Abstract available


  77. PEROTIN JM, Djukanovic R, Davies DE
    Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019;54.
    PubMed    


  78. HIEMSTRA PS, Sterk PJ
    Translation of in vitro findings to patients with asthma: a timely and compelling challenge.
    Eur Respir J. 2019;54.
    PubMed    


  79. WARD C, Kharaba ZJ
    Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019;54.
    PubMed    


  80. ANNESI-MAESANO I, Forastiere F
    Doubts about the adverse effects of air pollution on asthma?
    Eur Respir J. 2019;54.
    PubMed    


  81. WARK PAB
    Why are people with asthma more susceptible to influenza?
    Eur Respir J. 2019;54.
    PubMed    


    September 2019
  82. HOLGUIN F, Cardet JC, Chung KF, Diver S, et al
    Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline.
    Eur Respir J. 2019 Sep 26. pii: 13993003.00588-2019.
    PubMed     Abstract available


  83. MAIJERS I, Kearns N, Harper J, Weatherall M, et al
    Oral steroid sparing effect of high dose inhaled corticosteroids in asthma.
    Eur Respir J. 2019 Sep 26. pii: 13993003.01147-2019.
    PubMed     Abstract available


  84. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    Diagnosis of asthma in children: the contribution of a detailed history and test results.
    Eur Respir J. 2019 Sep 12. pii: 13993003.01326-2019.
    PubMed     Abstract available


  85. HILES SA, McDonald VM, Guilhermino M, Brusselle GG, et al
    Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis.
    Eur Respir J. 2019 Sep 12. pii: 13993003.01381-2019.
    PubMed     Abstract available


  86. LEE H, Ryu J, Nam E, Chung SJ, et al
    Increased Mortality in Patients with Corticosteroid-dependent Asthma: A Nationwide Population-based Study.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00804-2019.
    PubMed     Abstract available


  87. BRINKMAN P, Ahmed WM, Gomez C, Knobel HH, et al
    Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00544-2019.
    PubMed     Abstract available


  88. ARDURA-GARCIA C, Arias E, Hurtado P, Bonnett LJ, et al
    Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study.
    Eur Respir J. 2019 Sep 12. pii: 13993003.02419-2018.
    PubMed     Abstract available


  89. LJUNGBERG H, Carleborg A, Gerber H, Ofverstrom C, et al
    Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial.
    Eur Respir J. 2019 Sep 3. pii: 13993003.00983-2019.
    PubMed     Abstract available


  90. PUHAN MA
    Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice.
    Eur Respir J. 2019;54.
    PubMed    


  91. SOLTANI A, Mahmood MQ, Reid DW, Walters EH, et al
    Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation.
    Eur Respir J. 2019;54.
    PubMed    


  92. SUISSA S
    Inhaled corticosteroids and pneumonia mortality in COPD patients.
    Eur Respir J. 2019;54.
    PubMed    


  93. SUISSA S, Ariel A
    Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
    Eur Respir J. 2019;54.
    PubMed    


  94. ALMAGRO P, Martinez-Camblor P, Soriano JB
    Inhaled corticosteroids and pneumonia mortality in COPD patients.
    Eur Respir J. 2019;54.
    PubMed    


  95. HARTLEY B, Criner GJ, Dransfield MT, Halpin DMG, et al
    Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
    Eur Respir J. 2019;54.
    PubMed    


  96. FOWLER SJ, Sterk PJ
    Breath biomarkers in asthma: we're getting answers, but what are the important questions?
    Eur Respir J. 2019;54.
    PubMed    


  97. SPINOU A, Chalmers JD
    Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?
    Eur Respir J. 2019;54.
    PubMed    


    August 2019
  98. BOURDIN A, Bjermer L, Brightling C, Brusselle G, et al
    ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions.
    Eur Respir J. 2019 Aug 29. pii: 13993003.00900-2019.
    PubMed     Abstract available


  99. EVERAERTS S, McDonough JE, Verleden SE, Josipovic I, et al
    Airway morphometry in COPD with bronchiectasis: a view on all airway generations.
    Eur Respir J. 2019 Aug 29. pii: 13993003.02166-2018.
    PubMed     Abstract available


  100. RINGSHAUSEN FC, Rademacher J, Pink I, de Roux A, et al
    Increasing bronchiectasis prevalence in Germany, 2009-2017: a population-based cohort study.
    Eur Respir J. 2019 Aug 29. pii: 13993003.00499-2019.
    PubMed    


  101. BULLONE M, Carriero V, Bertolini F, Folino A, et al
    Elevated serum IgE, OCS-dependence and IL-17/22 expression in highly neutrophilic asthma.
    Eur Respir J. 2019 Aug 22. pii: 13993003.00068-2019.
    PubMed     Abstract available


  102. KELLY RS, Chawes BL, Guo F, Zhang L, et al
    The Role of the 17q21 Genotype in the Prevention of Early Childhood Asthma and Recurrent Wheeze by Vitamin D.
    Eur Respir J. 2019 Aug 22. pii: 13993003.00761-2019.
    PubMed     Abstract available


  103. CHACHI L, Diver S, Kaul H, Rebelatto MC, et al
    Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma.
    Eur Respir J. 2019 Aug 7. pii: 13993003.00930-2019.
    PubMed    


  104. TOREN K, Olin AC, Johnsson A, Vikgren J, et al
    The association between cadmium exposure and chronic airflow limitation and emphysema: The Swedish CArdioPulmonary BioImage Study (SCAPIS Pilot).
    Eur Respir J. 2019 Aug 7. pii: 13993003.00960-2019.
    PubMed    


  105. JHA A, Dunning J, Tunstall T, Thwaites RS, et al
    Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza.
    Eur Respir J. 2019 Aug 7. pii: 13993003.00949-2019.
    PubMed     Abstract available


  106. KHREIS H, Cirach M, Mueller N, de Hoogh K, et al
    Outdoor Air Pollution and the Burden of Childhood Asthma across Europe.
    Eur Respir J. 2019 Aug 7. pii: 13993003.02194-2018.
    PubMed     Abstract available


  107. PEJLER G
    The emerging role of mast cell proteases in asthma.
    Eur Respir J. 2019 Aug 1. pii: 13993003.00685-2019.
    PubMed     Abstract available


  108. SUOJALEHTO H, Suuronen K, Cullinan P
    Specific challenge testing for occupational asthma: revised handbook.
    Eur Respir J. 2019;54.
    PubMed    


  109. GAGA M, Khaltaev N, Varghese C
    Inhaled corticosteroids in asthma and the need for universal health coverage.
    Eur Respir J. 2019;54.
    PubMed    


  110. LAUBHAHN K, Schaub B
    Paediatric severe asthma: a need for novel innate molecular phenotypes.
    Eur Respir J. 2019;54.
    PubMed    


  111. BOEHM A, Pizzini A, Sonnweber T, Loeffler-Ragg J, et al
    Using Google Trends to investigate global COPD awareness.
    Eur Respir J. 2019;54.
    PubMed    


  112. ZHAO CN, Wu Q, Pan HF
    Using Google Trends to investigate global COPD awareness.
    Eur Respir J. 2019;54.
    PubMed    


    July 2019
  113. SINTOBIN I, Siroux V, Holtappels G, Pison C, et al
    Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort.
    Eur Respir J. 2019 Jul 8. pii: 13993003.00198-2019.
    PubMed     Abstract available


  114. AZIM A, Barber C, Dennison P, Riley J, et al
    Exhaled volatile organic compounds in adult asthma: a systematic review.
    Eur Respir J. 2019 Jul 4. pii: 13993003.00056-2019.
    PubMed     Abstract available


  115. BOULET LP, Reddel H, Bateman E, Pedersen S, et al
    The Global Initiative for Asthma (GINA): 25 years later.
    Eur Respir J. 2019 Jul 4. pii: 13993003.00598-2019.
    PubMed     Abstract available


  116. LASKA IF, Chalmers JD
    Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?
    Eur Respir J. 2019;54.
    PubMed    



  117. "Do bacteria have a role in asthma development?" J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469-471.
    Eur Respir J. 2019;54.
    PubMed    


  118. MILANZI EB, Gehring U
    Detrimental effects of air pollution on adult lung function.
    Eur Respir J. 2019;54.
    PubMed    


  119. LU W, Sharma P, Eapen MS, Sohal SS, et al
    Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis.
    Eur Respir J. 2019;54.
    PubMed    


    June 2019
  120. PERSSON C
    In vivo observations provide insight into roles of eosinophils and epithelial cells in asthma.
    Eur Respir J. 2019 Jun 27. pii: 13993003.00470-2019.
    PubMed     Abstract available


  121. WILKINSON M, Maidstone R, Loudon A, Blaikley J, et al
    Circadian rhythm of exhaled biomarkers in health and asthma.
    Eur Respir J. 2019 Jun 20. pii: 13993003.01068-2019.
    PubMed     Abstract available


  122. JANSON C, Malinovschi A, Amaral AFS, Accordini S, et al
    Bronchodilator reversibility in asthma and COPD: Findings from three large population studies.
    Eur Respir J. 2019 Jun 20. pii: 13993003.00561-2019.
    PubMed     Abstract available


  123. FLEMING M, Fitton CA, Steiner MFC, McLay JS, et al
    Educational and health outcomes of children treated for asthma: Scotland-wide record linkage study of 683,716 children.
    Eur Respir J. 2019 Jun 13. pii: 13993003.02309-2018.
    PubMed     Abstract available


  124. NAGAKUMAR P, Puttur F, Gregory LG, Denney L, et al
    Pulmonary type2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids.
    Eur Respir J. 2019 Jun 4. pii: 13993003.01809-2018.
    PubMed     Abstract available


  125. OSCULLO YEPEZ G, Sierra-Parraga JM, Posadas Blazquez T, Martinez-Garcia MA, et al
    Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination?
    Eur Respir J. 2019;53.
    PubMed    


  126. REDDEL HK, FitzGerald JM, Bateman ED, Bacharier LB, et al
    GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.
    Eur Respir J. 2019;53.
    PubMed    


  127. SORIANO JB
    The evolution of COPD species; or, something is changing for good in COPD.
    Eur Respir J. 2019;53.
    PubMed    


  128. SEIJO LM, Soriano JB, Peces-Barba G
    New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD.
    Eur Respir J. 2019;53.
    PubMed    


    May 2019
  129. SHOEMARK A, Cant E, Carreto L, Smith A, et al
    A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Eur Respir J. 2019 May 31. pii: 13993003.00303-2019.
    PubMed     Abstract available


  130. RAVI A, Chowdhury S, Dijkhuis A, Bonta PI, et al
    Neutrophilic inflammation in asthma and defective epithelial translational control.
    Eur Respir J. 2019 May 20. pii: 13993003.00547-2019.
    PubMed     Abstract available


  131. VOGELBERG C, Szefler SJ, Vrijlandt EJLE, Boner AL, et al
    Tiotropium add-on therapy is safe and reduces seasonal worsenings in paediatric asthma patients.
    Eur Respir J. 2019 May 16. pii: 13993003.01824-2018.
    PubMed     Abstract available


  132. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma.
    Eur Respir J. 2019 May 2. pii: 13993003.01580-2018.
    PubMed    


  133. CHOI H, Yang B, Nam H, Kyoung DS, et al
    Population-based prevalence of bronchiectasis and associated comorbidities in South Korea.
    Eur Respir J. 2019 May 2. pii: 13993003.00194-2019.
    PubMed    


  134. HOLLEY S, Knibb R, Latter S, Liossi C, et al
    Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ).
    Eur Respir J. 2019 May 2. pii: 13993003.01375-2018.
    PubMed     Abstract available


  135. O'BYRNE P, Fabbri LM, Pavord ID, Papi A, et al
    Asthma progression and mortality: The role of inhaled corticosteroids.
    Eur Respir J. 2019 May 2. pii: 13993003.00491-2019.
    PubMed     Abstract available


  136. MCBRIEN CN, Menzies-Gow A
    Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials.
    Eur Respir J. 2019;53.
    PubMed    


  137. SCHLEICH F, Louis R
    It needs more than just eosinophils to cause emphysema in COPD.
    Eur Respir J. 2019;53.
    PubMed    


  138. WALSH JA, Maddocks M, Man WD
    Supplemental oxygen during exercise training in COPD: full of hot air?
    Eur Respir J. 2019;53.
    PubMed    


  139. SCHUETZ P, Stolz D
    Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall.
    Eur Respir J. 2019;53.
    PubMed    


    April 2019
  140. PILLARISETTI N, Broderick D, Ainsworth A, Mulholland A, et al
    The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00704-2019.
    PubMed    


  141. PEROTIN JM, Schofield JPR, Wilson SJ, Ward J, et al
    Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00453-2019.
    PubMed    


  142. HENKLE E, Curtis JR, Chen L, Chan B, et al
    Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.
    Eur Respir J. 2019 Apr 18. pii: 13993003.01896-2018.
    PubMed     Abstract available


  143. TABEZE L, Marchand-Adam S, Borie R, Justet A, et al
    Severe asthma with blood hypereosinophilia associated with JAK2V617F mutation: a case series.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02248-2018.
    PubMed    


  144. EFTHIMIOU J, Poll C, Barnes PJ
    Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02390-2018.
    PubMed     Abstract available


  145. LEHTO K, Pedersen NL, Almqvist C, Lu Y, et al
    Asthma and affective traits in adults: a genetically informative study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02142-2018.
    PubMed     Abstract available


  146. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    PubMed    


  147. NANNINI LJ
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    PubMed    


  148. MARTIN MJ, Harrison TW
    Is it time to move away from short-acting beta-agonists in asthma management?
    Eur Respir J. 2019;53.
    PubMed    


  149. BOUSQUET J
    Electronic clinical decision support system (eCDSS) in the management of asthma: from theory to practice.
    Eur Respir J. 2019;53.
    PubMed    


  150. HOBBS BD, Tantisira KG
    MicroRNAs in COPD: small molecules with big potential.
    Eur Respir J. 2019;53.
    PubMed    


  151. ASHDOWN H, Steiner M
    Delivering high value therapies in COPD: the secret is in the marketing.
    Eur Respir J. 2019;53.
    PubMed    


  152. WOUTERS EFM
    The Medusa faces of dyspnoea in COPD.
    Eur Respir J. 2019;53.
    PubMed    


  153. SUISSA S, Ariel A
    Triple therapy in COPD: only for the right patient.
    Eur Respir J. 2019;53.
    PubMed    


  154. PAPI A, Petruzzelli S, Vezzoli S, Georges G, et al
    Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.
    Eur Respir J. 2019;53.
    PubMed    


    March 2019
  155. JIANG Y, Gruzieva O, Wang T, Forno E, et al
    Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents.
    Eur Respir J. 2019 Mar 28. pii: 13993003.00102-2019.
    PubMed     Abstract available


  156. WANG J, Pindus M, Janson C, Sigsgaard T, et al
    Dampness, mould, onset and remission of adult respiratory symptoms, asthma and rhinitis.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01921-2018.
    PubMed     Abstract available


  157. KUO CR, Lipworth B
    Differences in asthma control and lung function in relation to allergic status.
    Eur Respir J. 2019 Mar 17. pii: 13993003.02102-2018.
    PubMed    


  158. PAPAKONSTANTINOU E, Savic S, Siebeneichler A, Strobel W, et al
    A pilot study to test the feasibility of histological characterisation of asthma-COPD overlap.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01941-2018.
    PubMed    


  159. SHAHEEN SO, Lundholm C, Brew BK, Almqvist C, et al
    Prescribed analgesics in pregnancy and risk of childhood asthma.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01090-2018.
    PubMed     Abstract available


  160. MOKOKA MC, McDonnell MJ, MacHale E, Cushen B, et al
    Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy. Results from a systematic literature review and modelling study.
    Eur Respir J. 2019 Mar 7. pii: 13993003.02161-2018.
    PubMed     Abstract available


    February 2019
  161. BLOOM CI, Saglani S, Feary J, Jarvis D, et al
    Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006-2016.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02130-2018.
    PubMed     Abstract available


  162. DEN DEKKER HT, Burrows K, Felix JF, Salas LA, et al
    Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course.
    Eur Respir J. 2019 Feb 14. pii: 13993003.01795-2018.
    PubMed     Abstract available


  163. GUPTA S, Price C, Agarwal G, Chan D, et al
    The Electronic Asthma Management System (eAMS) Improves Primary Care Asthma Management.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02241-2018.
    PubMed     Abstract available


  164. DOYLE AD, Mukherjee M, LeSuer WE, Bittner TB, et al
    Eosinophil-derived IL-13 Promotes Emphysema.
    Eur Respir J. 2019 Feb 6. pii: 13993003.01291-2018.
    PubMed     Abstract available


  165. NAIR P, O'Byrne PM
    The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.
    Eur Respir J. 2019;53.
    PubMed    


  166. SHTEINBERG M, Shah A, Elborn JS
    New insights into immunological responses to infection in bronchiectasis.
    Eur Respir J. 2019;53.
    PubMed    


  167. PAHUS L, Jaffuel D, Vachier I, Bourdin A, et al
    Randomised controlled trials in severe asthma: selection by phenotype or stereotype.
    Eur Respir J. 2019;53.
    PubMed    


  168. GUAN WJ, Han XR, de la Rosa-Carrillo D, Martinez-Garcia MA, et al
    The significant global economic burden of bronchiectasis: a pending matter.
    Eur Respir J. 2019;53.
    PubMed    


    January 2019
  169. VAN DER MEER AN, de Jong K, Hoekstra-Kuik A, Bel EH, et al
    Dynamic hyperinflation impairs daily life activity in asthma.
    Eur Respir J. 2019 Jan 24. pii: 13993003.01500-2018.
    PubMed     Abstract available


  170. CHEN R, Zhang Q, Chen S, Tang H, et al
    IL-17F, rather than IL-17A, underlies airway inflammation in a steroid insensitive toluene diisocyanate-induced asthma model.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01510-2018.
    PubMed     Abstract available


  171. COTTIN V, Azuma A, Raghu G, Stansen W, et al
    Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01655-2018.
    PubMed    


  172. CRAMER N, Sedlacek L, Tummler B, Welte T, et al
    Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02191-2018.
    PubMed    


  173. PIETERS A, Bakker M, Hoek RAS, Altenburg J, et al
    The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral center.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02081-2018.
    PubMed    


  174. ROTH M, Stolz D
    Biomarkers and personalised medicine for asthma.
    Eur Respir J. 2019;53.
    PubMed    


  175. METERSKY ML, ZuWallack RL
    Pulmonary rehabilitation for bronchiectasis: if not now, when?
    Eur Respir J. 2019;53.
    PubMed    


    December 2018
  176. TONGA KO, Berend N, Thamrin C, Farah CS, et al
    Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01028-2018.
    PubMed    


  177. PAVLIDIS S, Takahashi K, Kwong FNK, Xie J, et al
    "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00938-2018.
    PubMed     Abstract available


  178. PATEL S, Cole AD, Nolan CM, Barker RE, et al
    Pulmonary rehabilitation in bronchiectasis: a propensity matched study.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01264-2018.
    PubMed     Abstract available


  179. DIEL R, Chalmers JD, Rabe KF, Nienhaus A, et al
    Economic burden of bronchiectasis in Germany.
    Eur Respir J. 2018 Dec 5. pii: 13993003.02033-2018.
    PubMed     Abstract available


    November 2018
  180. HANSEN AV, Ali Z, Malchau SS, Blafoss J, et al
    Fertility treatment among women with asthma - A case-control study of 3689 women with live births.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00597-2018.
    PubMed     Abstract available


  181. TUOMISTO LE, Ilmarinen P, Lehtimaki L, Tommola M, et al
    Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00904-2018.
    PubMed     Abstract available


  182. SHRIMANKER R, Pavord ID, Yancey S, Heaney LG, et al
    Exacerbations of severe asthma in patients treated with Mepolizumab.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01127-2018.
    PubMed    


  183. WELLS JM, Colangelo LA, Sivarajan L, Thyagarajan B, et al
    Inflammation and Endothelial Activation in Early Adulthood are Associated with Future Emphysema: The CARDIA Lung Study.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01532-2018.
    PubMed    


  184. BUSSE WW, Brusselle GG, Korn S, Kuna P, et al
    Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
    Eur Respir J. 2018 Nov 15. pii: 13993003.00948-2018.
    PubMed     Abstract available


  185. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2018;52.
    PubMed    


  186. SKOPELJA-GARDNER S, Theprungsirikul J, Meagher RE, Beliveau CM, et al
    Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response.
    Eur Respir J. 2018 Nov 1. pii: 13993003.01891-2018.
    PubMed    


  187. ALIBERTI S, Polverino E, Chalmers JD, Altenburg J, et al
    The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.
    Eur Respir J. 2018;52.
    PubMed    


  188. DJUKANOVIC R, Adcock IM, Anderson G, Bel EH, et al
    The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.
    Eur Respir J. 2018;52.
    PubMed    


    October 2018
  189. BROWN T, Jones T, Gove K, Barber C, et al
    Randomised Controlled Trials in Severe Asthma: Selection by Phenotype or Stereotype.
    Eur Respir J. 2018 Oct 25. pii: 13993003.01444-2018.
    PubMed     Abstract available


  190. RUSCONI F, Fernandes RM, Pijnenburg MWH, Grigg J, et al
    The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers.
    Eur Respir J. 2018;52.
    PubMed    


    September 2018
  191. CONTRERAS ZA, Chen Z, Roumeliotaki T, Annesi-Maesano I, et al
    Does early-onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts.
    Eur Respir J. 2018 Sep 12. pii: 13993003.00504-2018.
    PubMed     Abstract available


  192. VOLMER T, Effenberger T, Trautner C, Buh R, et al
    Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature.
    Eur Respir J. 2018 Sep 6. pii: 13993003.00703-2018.
    PubMed     Abstract available


  193. BOAVENTURA R, Sibila O, Agusti A, Chalmers JD, et al
    Treatable traits in bronchiectasis.
    Eur Respir J. 2018;52.
    PubMed    


  194. ARDURA-GARCIA C, Pedersen ESL, Goutaki M
    The limitations of cross-sectional data: perinatal risk factors for asthma.
    Eur Respir J. 2018;52.
    PubMed    


  195. ADLER D
    Bridging the gap in knowledge between dyspnoea scientists and clinicians.
    Eur Respir J. 2018;52.
    PubMed    


    August 2018
  196. BLEECKER ER, Wechsler ME, Mark FitzGerald J, Menzies-Gow A, et al
    Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe Asthma.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00936-2018.
    PubMed     Abstract available


  197. MILANZI EB, Koppelman GH, Smit HA, Wijga AH, et al
    Air pollution exposure and lung function until age 16: the PIAMA birth cohort study.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00218-2018.
    PubMed     Abstract available


  198. GOSENS R, Gross N
    The mode of action of anticholinergics in asthma.
    Eur Respir J. 2018 Aug 16. pii: 13993003.01247-2017.
    PubMed     Abstract available


  199. BEDARD A, Northstone K, Holloway JW, Henderson AJ, et al
    Maternal dietary antioxidant intake in pregnancy and childhood respiratory and atopic outcomes: birth cohort study.
    Eur Respir J. 2018 Aug 9. pii: 13993003.00507-2018.
    PubMed     Abstract available


  200. WESTBERG AP, Salonen MK, von Bondsdorff M, Osmond C, et al
    Maternal adiposity in pregnancy and offspring asthma in adulthood.
    Eur Respir J. 2018 Aug 2. pii: 13993003.01152-2018.
    PubMed    


  201. MARTIN JG
    Airway smooth muscle may drive mucus hypersecretion in asthma.
    Eur Respir J. 2018;52.
    PubMed    


  202. CULVER BH
    Assessment of severity and prognosis in COPD: moving beyond percent of predicted.
    Eur Respir J. 2018;52.
    PubMed    


    July 2018
  203. AGARWAL R, Dhooria S, Singh Sehgal I, Aggarwal AN, et al
    A randomized trial of voriconazole and prednisolone monotherapy in acute-stage ABPA complicating asthma.
    Eur Respir J. 2018 Jul 26. pii: 13993003.01159-2018.
    PubMed    


  204. POLVERINO E, Dimakou K, Hurst J, Angel Martinez-Garcia M, et al
    The overlap between bronchiectasis and chronic airways diseases: state of the art and future directions.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00328-2018.
    PubMed     Abstract available


  205. LEX C, Reuter M, Schuster A, Grabenhenrich L, et al
    Lung function trajectories using different reference equations in a birth cohort study up to the age of 20 years.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00364-2018.
    PubMed    


  206. MES MA, Katzer CB, Chan AHY, Wileman V, et al
    Pharmacists and medication adherence in asthma: a systematic review and meta-analysis.
    Eur Respir J. 2018 Jul 5. pii: 13993003.00485-2018.
    PubMed     Abstract available


  207. ALLEN DJ, Holmes LJ, Hince KA, Daly R, et al
    Non-adherence with inhaled preventer therapy in severe asthmatic patients on long term Omalizumab.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01025-2018.
    PubMed    


  208. ZHANG M, Litonjua AA, Mueller NT
    Maternal antibiotic use and child asthma: is the association causal?
    Eur Respir J. 2018;52.
    PubMed    


  209. ANDRIANASOLO RM, Kesse-Guyot E, Adjibade M, Hercberg S, et al
    Associations between dietary scores with asthma symptoms and asthma control in adults.
    Eur Respir J. 2018;52.
    PubMed     Abstract available



  210. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecke
    Eur Respir J. 2018;52.
    PubMed    


  211. YOHANNES AM
    Serotonergic antidepressants in COPD: beneficial or harmful?
    Eur Respir J. 2018;52.
    PubMed    


  212. ERNST P
    Blood eosinophils in COPD and the future risk of pneumonia.
    Eur Respir J. 2018;52.
    PubMed    


    June 2018
  213. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR).
    Eur Respir J. 2018 Jun 25. pii: 13993003.01927-2017.
    PubMed     Abstract available


  214. FAIZ A, Weckmann M, Tasena H, Vermeulen CJ, et al
    Profiling of healthy and asthmatic airway smooth muscle cells following IL-1beta treatment: a novel role for CCL20 in chronic mucus hyper-secretion.
    Eur Respir J. 2018 Jun 25. pii: 13993003.00310-2018.
    PubMed     Abstract available


  215. GOEMINNE CP, Cox B, Finch S, Loebinger MR, et al
    The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis.
    Eur Respir J. 2018 Jun 14. pii: 13993003.02557-2017.
    PubMed     Abstract available


  216. MAC AOGAIN M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, et al
    IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00766-2018.
    PubMed     Abstract available


  217. RONIT A, Kristensen T, Hoseth VS, Abou-Kassem D, et al
    Computed tomography quantification of emphysema in people living with HIV and uninfected controls.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00296-2018.
    PubMed     Abstract available


  218. GOMEZ REAL F, Burgess JA, Villani S, Dratva J, et al
    Maternal age at delivery, lung function and asthma in offspring: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  219. SUGIYAMA T
    A multi-organ loss of tissue phenotype in COPD: involvement of the functional muscle-bone unit.
    Eur Respir J. 2018;51.
    PubMed    


  220. RICCI F, Wollmer P, Engstrom G, Fedorowski A, et al
    Dysregulation of the "inflammatory reflex" with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD.
    Eur Respir J. 2018;51.
    PubMed    


  221. ANDREAS S
    The association of cardiovascular autonomic dysfunction and the prediction of COPD can be explained by neurohumoral activation.
    Eur Respir J. 2018;51.
    PubMed    


    May 2018
  222. DUFETELLE E, Bokov P, Delclaux C, Beydon N, et al
    Should reversibility be assessed in all asthmatic children with normal spirometry?
    Eur Respir J. 2018 May 31. pii: 13993003.00373-2018.
    PubMed    


  223. HYLAND ME, Jones RC, Lanario JW, Masoli M, et al
    The construction and validation of the Severe Asthma Questionnaire (SAQ).
    Eur Respir J. 2018 May 24. pii: 13993003.00618-2018.
    PubMed     Abstract available


  224. SANDRI BJ, Kaplan A, Hodgson SW, Peterson M, et al
    Multi-Omic Molecular Profiling of Lung Cancer in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2018 May 24. pii: 13993003.02665-2017.
    PubMed     Abstract available


  225. BIDAD N, Barnes N, Griffiths C, Horne R, et al
    UNDERSTANDING PATIENTS' PERCEPTIONS OF ASTHMA CONTROL: A QUALITATIVE STUDY.
    Eur Respir J. 2018 May 17. pii: 13993003.01346-2017.
    PubMed     Abstract available


  226. BURGE PS, Moore VC, Robertson AS, Walters GI, et al
    Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
    Eur Respir J. 2018 May 10. pii: 13993003.00059-2018.
    PubMed     Abstract available


  227. BOURBEAU J, Farias R
    Making sense of telemedicine in the management of COPD.
    Eur Respir J. 2018;51.
    PubMed    


  228. EKSTROM M, Elmberg V, Lindow T, Wollmer P, et al
    Breathlessness measurement should be standardised for the level of exertion.
    Eur Respir J. 2018;51.
    PubMed    


  229. BUSSE WW
    Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
    Eur Respir J. 2018;51.
    PubMed    


  230. SCHEERENS C, Beernaert K, Pype P, Cohen J, et al
    Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed    


    April 2018
  231. LOEWEN K, Monchka B, Mahmud SM, Jong G', et al
    Prenatal antibiotic exposure and childhood asthma: a population-based study.
    Eur Respir J. 2018 Apr 20. pii: 13993003.02070-2017.
    PubMed     Abstract available


  232. TSAI YH, Parker JS, Yang IV, Kelada SNP, et al
    Meta-Analysis of Airway Epithelia Gene Expression in Asthma.
    Eur Respir J. 2018 Apr 12. pii: 13993003.01962-2017.
    PubMed     Abstract available


  233. TAKAHASHI K, Pavlidis S, Ng Kee Kwong F, Hoda U, et al
    Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.
    Eur Respir J. 2018 Apr 12. pii: 13993003.02173-2017.
    PubMed     Abstract available


  234. HAVET A, Zerimech F, Sanchez M, Siroux V, et al
    Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  235. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Ekstrom M, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed    


  236. RAMOS HERNANDEZ C, Nunez Fernandez M, Mouronte-Roibas C, Mosteiro Anon M, et al
    HypAir FeNO: an electrochemical sensor.
    Eur Respir J. 2018;51.
    PubMed    


    March 2018
  237. HANCOX RJ, Pavord ID, Sears MR
    Associations between blood eosinophils and decline in lung function among adults with and without asthma.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02536-2017.
    PubMed     Abstract available


  238. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    PubMed     Abstract available


  239. SHTEINBERG M, Stein N, Adir Y, Ken-Dror S, et al
    Prevalence, risk factors and prognosis of Non tuberculous mycobacteria infection among people with bronchiectasis: a population survey.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02469-2017.
    PubMed    


  240. CHANOINE S, Sanchez M, Pin I, Temam S, et al
    Multimorbidity-medications and poor asthma prognosis.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02114-2017.
    PubMed     Abstract available


  241. TO T, Feldman LY, Zhu J, Gershon AS, et al
    Asthma Health Services Utilization Before, During, and After Pregnancy: A Population-Based Cohort Study.
    Eur Respir J. 2018 Mar 8. pii: 13993003.00209-2018.
    PubMed     Abstract available


  242. LEE J, Ren Tay T, Radhakrishna N, Hore-Lacy F, et al
    Non-adherence in the era of severe asthma biologics and thermoplasty.
    Eur Respir J. 2018 Mar 8. pii: 13993003.01836-2017.
    PubMed     Abstract available


  243. DIJK FN, Xu C, Melen E, Carsin AE, et al
    Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  244. HESTER KLM, Newton J, Rapley T, Ryan V, et al
    Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era.
    Eur Respir J. 2018 Mar 1. pii: 13993003.02402-2017.
    PubMed    


  245. PATTINSON KTS, Rowland MJ, Nickol AH, Quinlan J, et al
    Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain.
    Eur Respir J. 2018;51.
    PubMed    


    February 2018
  246. PERRY MM, Lavender P, Scott Kuo CH, Galea F, et al
    DNA methylation modules in airway smooth muscle are associated with asthma severity.
    Eur Respir J. 2018 Feb 15. pii: 13993003.01068-2017.
    PubMed    


  247. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  248. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    PubMed    



  249. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    PubMed    


  250. MARTINEZ-GARCIA MA
    Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers.
    Eur Respir J. 2018;51.
    PubMed    


  251. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  252. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    PubMed     Abstract available


  253. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed    


  254. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    PubMed    


  255. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  256. CELLI BR, Locantore N, Tal-Singer R, Riley J, et al
    Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  257. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  258. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  259. SIMILOWSKI T
    Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases.
    Eur Respir J. 2018;51.
    PubMed    


  260. CRINER GJ
    Revising our approach to conducting therapeutic clinical research in COPD.
    Eur Respir J. 2018;51.
    PubMed    


  261. HALPIN DMG
    Palliative care for people with COPD: effective but underused.
    Eur Respir J. 2018;51.
    PubMed    


  262. SORIANO JB, Burgel PR
    On Don Quixote and pink puffers: multi-organ loss of tissue COPD.
    Eur Respir J. 2018;51.
    PubMed    


  263. JONES R
    The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions?
    Eur Respir J. 2018;51.
    PubMed    


  264. SOHAL SS
    Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules.
    Eur Respir J. 2018;51.
    PubMed    


    January 2018
  265. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    PubMed    


  266. CHALMERS JD, Polverino E
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed    


  267. GUAN WJ, Huang Y, Chen CL, Chen RC, et al
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed    


  268. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  269. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  270. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed    


  271. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed    


  272. WONG C, Sullivan C, Jayaram L
    ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence.
    Eur Respir J. 2018;51.
    PubMed    


  273. CHALMERS JD, Ringshausen FC, Harris B, Elborn JS, et al
    Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
    Eur Respir J. 2018;51.
    PubMed    


  274. MUNOZ G, de Gracia J, Buxo M, Alvarez A, et al
    Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  275. CHOTIRMALL SH, Chalmers JD
    RESPIRE: breathing new life into bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed    


  276. AKSAMIT T, De Soyza A, Bandel TJ, Criollo M, et al
    RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  277. DE SOYZA A, Aksamit T, Bandel TJ, Criollo M, et al
    RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  278. MACNAUGHTON J, Oxley R, Rose A, Russell A, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed    


  279. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Lansing R, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed    


  280. AMBROSINO N
    Inspiratory muscle training in stable COPD patients: enough is enough?
    Eur Respir J. 2018;51.
    PubMed    


  281. SPRUIT MA, Singh SJ, Rochester CL, Greening NJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    PubMed    


  282. FOWLER SJ
    Breath analysis for label-free characterisation of airways disease.
    Eur Respir J. 2018;51.
    PubMed    


  283. WILSON KC, Krishnan JA, Sliwinski P, Criner GJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    PubMed    


  284. VANFLETEREN LEGW, Ullman A, Fabbri LM
    Time for a longer and better life for patients with COPD.
    Eur Respir J. 2018;51.
    PubMed    


  285. BEASLEY R, Braithwaite I, Fingleton J, Weatherall M, et al
    The inhaled corticosteroid/long-acting beta-agonist maintenance and reliever therapy regimen: where to from here?
    Eur Respir J. 2018;51.
    PubMed    


  286. CLINI E, Castaniere I, Tonelli R
    Looking for a chronic care model in COPD patients.
    Eur Respir J. 2018;51.
    PubMed    


  287. SCHULTZ K, Jelusic D, Wittmann M, Kramer B, et al
    Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  288. BEAUMONT M, Mialon P, Le Ber C, Le Mevel P, et al
    Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  289. ALCAZAR-NAVARRETE B, Ruiz Rodriguez O, Conde Baena P, Romero Palacios PJ, et al
    Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  290. DE VRIES R, Dagelet YWF, Spoor P, Snoey E, et al
    Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  291. KESSLER R, Casan-Clara P, Koehler D, Tognella S, et al
    COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  292. ROSE L, Istanboulian L, Carriere L, Thomas A, et al
    Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD(+)): a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  293. STEURER-STEY C, Dalla Lana K, Braun J, Ter Riet G, et al
    Effects of the "Living well with COPD" intervention in primary care: a comparative study.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


    December 2017
  294. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed    


  295. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    PubMed    


  296. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed    


  297. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  298. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    PubMed    


  299. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed    


  300. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  301. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed    


  302. DESLEE G, Leroy S, Perotin JM, Mal H, et al
    Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
    Eur Respir J. 2017;50.
    PubMed    


  303. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


    November 2017
  304. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed    


  305. SALEH AD, Kwok B, Brown JS, Hurst JR, et al
    Correlates and assessment of excess cardiovascular risk in bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  306. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  307. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    PubMed    


    October 2017
  308. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  309. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  310. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed    


  311. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Abstract available



  312. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed    


  313. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed    


  314. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


    September 2017
  315. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed    


  316. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed    


  317. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  318. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed    


  319. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  320. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  321. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed    


  322. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Abstract available



  323. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed    


  324. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  325. CONRAD A, Janciauskiene S, Kohnlein T, Fuge J, et al
    Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation.
    Eur Respir J. 2017;50.
    PubMed    


    July 2017
  326. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed    


    June 2017
  327. SCHLAPBACH LJ, Straney L, Gelbart B, Alexander J, et al
    Burden of disease and change in practice in critically ill infants with bronchiolitis.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    May 2017
  328. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    April 2017
  329. O'DONNELL DE, Casaburi R, Frith P, Kirsten A, et al
    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  330. FANER R, Sibila O, Agusti A, Bernasconi E, et al
    The microbiome in respiratory medicine: current challenges and future perspectives.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  331. KNEIDINGER N, Milger K, Janitza S, Ceelen F, et al
    Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    March 2017
  332. STOCKLEY JA, Ismail AM, Hughes SM, Edgar R, et al
    Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  333. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  334. PERSSON LJ, Aanerud M, Hardie JA, Miodini Nilsen R, et al
    Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  335. HUSEBO GR, Gronseth R, Lerner L, Gyuris J, et al
    Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  336. WEDZICHA JA ERS CO-CHAIR, Miravitlles M, Hurst JR, Calverley PM, et al
    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  337. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  338. CROOK S, Busching G, Schultz K, Lehbert N, et al
    A multicentre validation of the 1-min sit-to-stand test in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  339. WILLIAMS MT, John D, Frith P
    Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  340. VOGELMEIER CF, Criner GJ, Martinez FJ, Anzueto A, et al
    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    February 2017
  341. LORX A, Czovek D, Gingl Z, Makan G, et al
    Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  342. MOLIMARD M, Raherison C, Lignot S, Balestra A, et al
    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  343. LOWES D, Al-Shair K, Newton PJ, Morris J, et al
    Predictors of mortality in chronic pulmonary aspergillosis.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    January 2017
  344. KARIMI R, Tornling G, Forsslund H, Mikko M, et al
    Differences in regional air trapping in current smokers with normal spirometry.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  345. BENMERAD M, Slama R, Botturi K, Claustre J, et al
    Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  346. KUNZ LI, Ten Hacken NH, Lapperre TS, Timens W, et al
    Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  347. GREULICH T, Nell C, Hohmann D, Grebe M, et al
    The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    November 2016
  348. HASEGAWA K, Mansbach JM, Ajami NJ, Espinola JA, et al
    Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.
    Eur Respir J. 2016;48:1329-1339.
    PubMed     Abstract available


    April 2016
  349. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Abstract available


    March 2016
  350. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: